Search Results for "Human Trafficking"
Displaying 1 - 20 of 25 results. 20 results shown per page. Page 1 of 2.
Antimicrobial Drugs - Market Returns Analysis
Publication Date
In 2017, at least 2.8 million people in the U.S. acquired serious infections with bacteria that are resistant to one or more antimicrobial drugs and 35,000 have died as a result. Resistance to antimicrobials is viewed as a global threat with antimicrobial drug use in human and animal health driving resistance.
Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program
Publication Date
The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.
Prescription Drug Pricing: ASPE Resources Related to Safe Harbor Rule
Publication Date
Department of Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson have issued a proposed rule, “Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in
Medicaid Contracts with Medicare Special Needs Plans Reflect Diverse State Approaches to Dually Eligible Beneficiaries
Publication Date
U.S. Department of Health and Human Services
Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001
Publication Date
U.S. Department of Health and Human Services
Evaluation of New Measures of Assistive Technology and the Home Environment from the 2005 Pilot Study of Technology and Aging
Publication Date
U.S. Department of Health and Human Services
Compendium of Home Modification and Assistive Technology Policy and Practice Across States: Final Report
Publication Date
U.S. Department of Health and Human Services
RFI on Potential Roles for HHS to Encourage Innovation and Diffusion of Medical Technologies that Enhance Health System Value
Publication Date
Request for Information on Potential Roles for HHS in Developing a Dynamic Environment to Encourage the Innovation and Diffusion of Medical Technologies that Enhance Health System Value
Continuation of Drug Risk Adjustment
Publication Date
Prepared by: National Opinion Research Center (NORC) at the University of Chicago Prepared for:U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
Cost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Publication Date
By: The Lewin Group, Inc. Prepared for: Office for Science and Data Policy Office of the Assistant Secretary for Planning and Evaluation
Evaluation of New Measures of Assistive Technology and the Home Environment from the 2005 Pilot Study of Technology and Aging
Publication Date
U.S. Department of Health and Human Services
Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report
Publication Date
U.S. Department of Health and Human Services Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report Part I. Recommended Modules and Instrument Development Process
The Graying of Medicare's Disabled Population: Implication for a Medicare Drug Benefit
Publication Date
U.S. Department of Health and Human Services
Issues in the Design and Implementation of Drug Formularies and Therapeutic Classes
Publication Date
Presented by: National Opinion Research Center (NORC) at The University of Chicago Submitted to: Steve Sheingold Office of the Assistant Secretary for Planning and Evaluation (ASPE)
Analysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IGIV)
Publication Date
Contents IGIV Supply and Distribution - Key Findings IGIV Demand - Key Fundings IGIV Access Problems- Key Fundings Immune globulin intravenous (IGIV), also referred to as intravenous immune globulin (IVIG), is a valuable treatment for many seriously ill patients. Although the U.S.
ASPE work on Drug Risk Adjustment
Publication Date
Report authors : Claudia-Schur, Jack Hoadley, Chris Hogan Office of the Assistant Secretary for Planning and Evaluation (ASPE)U.S. Department of Health and Human Services
Barriers to Implementing Technology in Residential Long-Term Care Settings
Publication Date
U.S. Department of Health and Human Services
Barriers to Implementing Technology in Residential Long-Term Care Settings
Publication Date
U.S. Department of Health and Human Services
Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001
Publication Date
U.S. Department of Health and Human Services
The Graying of Medicare's Disabled Population: Implication for a Medicare Drug Benefit
Publication Date
U.S. Department of Health and Human Services The Graying of Medicares Disabled Population: Implication for a Medicare Drug Benefit